While necessary, this phase transforms toxins into "reactive intermediate metabolites" that are frequently more toxic and volatile than the original substance, generating massive amounts of free radicals
Cycle structure (12-week block): Baseline labs: IGF-1, testosterone (total and free), cortisol, CBC, CMP, thyroid panel, inflammatory markers (hsCRP, IL-6), telomere length test (optional) Week 12: Introduce CJC-1295/Ipamorelin (5 nights per week, subcutaneous, pre-bed)
10.1016/s0092-8674(00)81732-8 Cell 43 CeniniG.LloretA.CascellaR
Other factors that deplete Glutathione: Diet - Lack of sulphur and vegetables in diet, pro-inflammatory diet, a diet low in anti-oxidants Lifestyle - Smoking, Drinking, Overtraining, Medications Environment - Poor air quality, radiation exposure, Industrial pollutants, Chemical exposures Health Conditions - Autoimmunity, Inflammatory conditions
Clinical Data Phase 2 clinical studies of cagrilintide monotherapy in adults with obesity reported dose-dependent weight reductions of 6.0% to 10.8% over 26 weeks with a favourable tolerability profile
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene